Help us reach our goal of $150,000 to fight for psychedelic freedom in Ontario's Court of Appeal. Donate now.
Donate now

Essais cliniques

Ressources :
Réduction des méfaits
Formation
Lecture
Événements
Psychedelics Media
Résultats de la recherche
Essais cliniques

Interactive Psychedelic Research Map

See the full Interactive Psychedelic Research Map on PsychoactiveMap.com

See map

Vous pourriez être admissible à participer à un essai de recherche sur les psychédéliques. Les études sur les substances psychédéliques en sont à différentes étapes et recrutent à la fois des volontaires en bonne santé et des personnes atteintes de problèmes de santé mentale particuliers. Nous avons compilé ici une liste des organismes de recherche susceptibles de recruter.

Research Recruiting

Aider à financer la recherche

Navigating the Canadian Psychedelic Renaissance from Below: Consumer Experiences and Motivations

Institution

McGill University

Location

Hybrid (Online and In-Person)

Effects of Decarboxylation Status, Dosage, Preparation Method, and BMI on Per ceived Therapeutic Benefits and Adverse Effects of Amanita muscaria: A Retrospective Self Administration Survey

Institution

University of Winchester

Location

Online

National KAP Provider Survey: Share Your Clinical Experience (15-20 min) | UAlbany IRB Study #00007287

Institution

University at Albany - State University of New York

Location

Online

Psilocybine

In Progress / Recruiting

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (P-TRD)

Promoteur

COMPASS Pathways

Population

Treatment Resistant Depression

In Progress / Recruiting

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

Promoteur

Johns Hopkins University

Population

Religious Professionals

In Progress / Recruiting

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

Promoteur

NYU Langone Health

Population

Religious Professionals

In Progress / Recruiting

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer’s Disease

Promoteur

Johns Hopkins University

Population

Neurocognitive Disorder or Clinical Dementia, and Depression

In Progress / Recruiting

Prophylactic Effects of Psilocybin on Chronic Cluster Headache (EPOCH)

Promoteur

Gitte Moos Knudsen

Population

Chronic Cluster Headache

In Progress / Recruiting

Psilocybin for Treatment of Obsessive Compulsive Disorder

Promoteur

University of Arizona

Population

OCD

Completed

Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence

Promoteur

Population

Psychedelic Assisted Therapists (PaT)

In Progress / Recruiting

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study

Promoteur

John Hopkins School of Medicine in collaboration with Beckley

Population

Smokers

In Progress / Recruiting

Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects

Promoteur

University Hospital, Basel, Switzerland

Population

In Progress / Recruiting

Effects of Psilocybin in Anorexia Nervosa

Promoteur

Johns Hopkins University

Population

Anorexia Nervosa

In Progress / Recruiting

Effects of Psilocybin in Post-Traumatic Headache

Promoteur

Yale University

Population

Post-Traumatic Headache

In Progress / Recruiting

Characterization of Altered Waking States of Consciousness in Healthy Humans

Promoteur

University of Zurich

Population

Healthy Volunteers

In Progress / Recruiting

A Study of Psilocybin for Major Depressive Disorder (MDD)

Promoteur

Usona Institute, Signant Health, The Emmes Company, LLC

Population

Major Depressive Disorder

In Progress / Recruiting

Adjunctive Effects of Psilocybin and Buprenorphine

Promoteur

University of Wisconsin, Heffter Research Institute

Population

Opioid Use Disorder

In Progress / Recruiting

A Double-blind Trial of Psilocybin-assisted Treatment of Alcohol Dependence Sponsor: NYU Langone Health in collaboration with Heffter Research Institute and University of New Mexico

Promoteur

Population

Alcohol Use Disorders